Actively Recruiting
Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions
Led by Centre Francois Baclesse · Updated on 2025-12-24
20
Participants Needed
1
Research Sites
406 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.
CONDITIONS
Official Title
Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with undifferentiated primary carcinoma (UPC) confirmed by histological and immunohistochemical evidence validated by local or national UPC multidisciplinary consultation
- Patient indicated for systemic first-line treatment at inclusion; treatment may have started but limited to 2 cycles
- Life expectancy greater than 3 months
- Patient of legal age
- Patient affiliated to a social security scheme
- Signed informed consent before any study procedures
You will not qualify if you...
- Persons deprived of liberty or under guardianship (including curatorship)
- Pregnant or breastfeeding patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre François Baclesse
Caen, France
Actively Recruiting
Research Team
Z
zoé NEVIERE, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here